Skip to content
Mushroom Retreats

Psilocybin law in Minnesota

Decriminalised or deprioritised Checked 26 October 2026

Psilocybin is illegal in Minnesota: it is a Schedule I controlled substance under Minn. Stat. §152.02, and 2026 bills for a therapeutic program failed, though the state's cannabis office was told to study one.

Psilocybin is still illegal, but state law reduces the penalty for personal possession, or one or more cities or counties have made it a lowest enforcement priority. Supplying it remains a crime. A summary of published sources, not legal advice.

Source status: Prohibited. Psilocybin remains a Schedule I drug under US federal law.

Scheduling

Psilocybin and psilocyn are listed in Schedule I, hallucinogens, Minn. Stat. §152.02 subd. 2(d)(21) and (22) [Minn. Stat. §152.02, Schedules of controlled substances, Minnesota Revisor of Statutes, read 26 October 2026]

What the law says

Local measures

Cities or counties that made psilocybin a low enforcement priority. Possession stays a state crime, and police outside these places are not bound.

Penalties

Bills

  • HF 2906 2025-2026 (94th Legislature)

    Psilocybin therapeutic use program established

    Would create a supervised therapeutic psilocybin program for adults 21 and over with qualifying conditions and move psilocybin from Schedule I to Schedule IV.

    Status: Passed House Health Finance and Policy Committee, re-referred to Commerce Finance and Policy 16 March 2026; died when the 2025-2026 biennium ended, 16 March 2026

  • HF 4577 2025-2026 (94th Legislature)

    Psilocybin therapeutic use program established

    Alternative therapeutic psilocybin program bill with an advisory committee and appropriation.

    Status: Re-referred to Veterans and Military Affairs Division 9 April 2026; died when the biennium ended, 9 April 2026

Dated changes

  • 9 April 2026: Alternative therapeutic psilocybin program bill with an advisory committee and appropriation. Status: Re-referred to Veterans and Military Affairs Division 9 April 2026; died when the biennium ended. Source
  • 16 March 2026: Would create a supervised therapeutic psilocybin program for adults 21 and over with qualifying conditions and move psilocybin from Schedule I to Schedule IV. Status: Passed House Health Finance and Policy Committee, re-referred to Commerce Finance and Policy 16 March 2026; died when the 2025-2026 biennium ended. Source

The full law map, with 51 US entries and every country we cover, or every dated change.